{"nct_id":"NCT02564523","title":"Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2015-11-06","start_date_type":"ACTUAL","primary_completion_date":"2019-02-12","primary_completion_date_type":"ACTUAL","completion_date":"2019-02-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}